Menopause & Hormone Panel

A comprehensive 39-biomarker hormonal assessment for women navigating perimenopause and menopause. Measures the full reproductive hormone suite (FSH, LH, oestradiol, progesterone, testosterone, DHEA-S, prolactin, SHBG), complete thyroid function, bone health markers (vitamin D, calcium, ALP), and metabolic indicators. Provides the data needed to understand hormonal shifts, guide treatment decisions, and monitor HRT effectiveness.

Perimenopause can begin up to 10 years before menopause, and its hormonal fluctuations cause symptoms that are frequently misdiagnosed as anxiety, depression, or 'just stress.' The Menopause & Hormone Panel provides the objective data to distinguish hormonal changes from other causes and to track the transition over time. FSH and LH reveal pituitary signalling — rising FSH is the hallmark of declining ovarian reserve. Oestradiol and progesterone levels confirm where you sit in the menopausal transition and whether symptoms correlate with hormonal troughs. Testosterone and DHEA-S — often overlooked in women's health — affect libido, energy, muscle mass, and cognitive function, declining gradually from the mid-30s. SHBG (sex hormone-binding globulin) determines how much of each hormone is actually bioavailable. Prolactin is included to rule out pituitary causes of cycle disruption. The thyroid panel is essential because thyroid dysfunction and perimenopause share overlapping symptoms (fatigue, weight gain, mood changes, hair loss) and frequently coexist. Bone health markers (vitamin D, calcium, ALP) establish a baseline before the accelerated bone loss that follows oestrogen decline. Iron studies and B12 address nutritional factors that compound hormonal symptoms. This panel gives women and their practitioners the complete picture needed for informed decisions about hormone replacement therapy, lifestyle modifications, and targeted supplementation.